CALB2 and lung adenocarcinoma: Since the positivity of calretinin in lung adenocarcinomas and renal cell carcinomas has been reported at a low rate of 0–10% in various publications, it is a useful marker in the differentiation of lung adenocarcinomas and renal cell carcinomas (Louw et al. 2022).